Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The new MRC talks podcast tells Professor Daniel Freeman’s career story – helping to improve lives through medical research.

Professor Daniel Freeman, Department of Psychiatry, University of Oxford, is a virtual reality pioneer and clinical psychologist. His career story features in the first episode of the new Medical Research Council's 2019 'career inspirations' podcast series.

MRC talks is a podcast telling the stories of inspiring scientists working to improve lives through medical research.

In this first episode, Debs Barber, MRC science content officer, talks to Professor Daniel Freeman about his career.

"I have dedicated my career to clinical research. The focus has been threefold: to understand what causes mental health disorders, to use that knowledge to develop better treatments, and to consider how treatment innovations will get to patients. The inspiration for many of the ideas has come from time spent listening, talking, and trying things out with individuals who have psychosis. There then follows an endeavour to test empirically that our insights are correct and that innovations – such as automating the delivery of psychological therapy using virtual reality – really do help patients."

The new series will feature 12 scientists, all working in different areas of medical research. Each episode, publishing on the first Wednesday of every month, will see a scientist share their career highlights, what makes them tick and their advice for forging a career in medical research.

Part of UK Research and Innovation, the MRC has been funding research dedicated to improving human health since 1913.

To Listen

Similar stories

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

Experimental Medicine and Industry Partnership

The recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between a core team of Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institute, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.